Merck KGaA (OTCMKTS:MKKGY) Sees Unusually-High Trading Volume – Here’s Why

Merck KGaA (OTCMKTS:MKKGY – Get Free Report) saw strong trading volume on Monday . Approximately 270,223 shares changed hands during mid-day trading, an increase of 197% from the previous session’s volume of 91,034 shares.The stock last traded at $30.06 and had previously closed at $30.46.

Analysts Set New Price Targets

A number of research firms recently commented on MKKGY. Jefferies Financial Group began coverage on Merck KGaA in a research note on Tuesday, May 26th. They set a “hold” rating on the stock. HSBC upgraded Merck KGaA to a “hold” rating in a research note on Monday, July 6th. UBS Group lowered Merck KGaA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 20th. Finally, Zacks Research cut Merck KGaA from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 20th. Six analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock presently has a consensus rating of “Hold”.

Get Merck KGaA alerts:

View Our Latest Report on Merck KGaA

Merck KGaA Price Performance

The company has a 50 day simple moving average of $32.05 and a 200 day simple moving average of $29.58. The company has a market capitalization of $19.49 billion, a price-to-earnings ratio of 15.54, a price-to-earnings-growth ratio of 2.83 and a beta of 0.96. The company has a quick ratio of 1.00, a current ratio of 1.51 and a debt-to-equity ratio of 0.36.

About Merck KGaA

(Get Free Report)

Merck KGaA is a Germany-based science and technology company headquartered in Darmstadt. Founded in 1668, it is one of the world’s oldest pharmaceutical and chemical businesses. Merck KGaA operates independently from the U.S.-based Merck & Co, Inc, which uses the name MSD in markets outside the United States and Canada.

The company operates through three primary business sectors: Life Science, Healthcare and Electronics. Its Life Science business supplies laboratory products, research tools, bioprocessing equipment and services used by academic institutions, pharmaceutical manufacturers and other industrial customers.

Further Reading

• Five stocks we like better than Merck KGaA
• Running on Empty: 3 Energy Plays for Europe’s Deep Freeze
• 3 Healthcare Stocks for 3 Stages of Life
• Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
• MarketBeat’s Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.